scottish widows has its eyes on the master trust prize
.
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
.
.
.
.
the uk�s initial plan had been challenged in court by the
.